Annette B. Håvik

• 09/17/2023 - 09/19/2023, Oslo, Nordic Precision Cancer Medicine, Acta Oncologica Conference
• 11/16/2022, The Norwegian Cancer Society's National Group of Expertise on Pancreatic Cancer, Research, Pancreatic Cancer Research in Norway - Present and Future
• 06/29/2022 - 06/30/2022, Bionano genomics, Bionano - analyse
• 05/04/2021 - 05/07/2021, The Hereditary Breast and Ovarian Cancer Foundation, Eighth International Symposium on hereditary breast and ovarian cancer – Virtual Edition
• 06/15/2015 - 06/16/2015, Oslo, Norge, Excel nivå 4 - Makro m. Visual Basic, KnowledgeGroup
• 04/23/2015, Gardermoen, Gastro-onkologisk Vårmøte 2015
• 11/05/2014 - 11/06/2014, Tromsø, Genetikkfaget ruster seg for fremtiden, Norsk forrening for medisinsk genetikk og Norsk selskap for human genetikk
• 10/10/2011, Det medisinske fakultet - Universitetet i Oslo, Helseforskningsrett: Etikk og personvern
• 12/13/2010 - 12/17/2010, Det medisinske fakultet - Universitetet i Oslo, Epigenetics, development and disease
• 03/08/2010 - 03/11/2010, Det medisinske fakultet - Universietet i Oslo, Logistic regression, survival analysis and Cox-regression
• 05/05/2008 - 05/22/2008, Universitetet i Oslo / Den norske lægeforening, Innføring i statistikk

Relevant academic experience

• Ph.D. 2. opponent, Thesis title: “Next Generation Sequencing based methods in genetic disease diagnostics”, 20.06.2023, Trondheim.

• Lecture at course for doctors in specialication: Variant classification in cancer genes 19.04.2023, Oslo

Publications

• Håvik AB*, Jeanmougin M*, Cekaite L*, Brandal P, Sveen A, Meling TR, Ågesen TH, Scheie D, Heim S, Lothe RA, Lind GE: Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment. Molecular Oncology 14: 1016-1027, 2020 *Shared first authors.
• Håvik AB, Lind GE, Honne H, Meling TR, Scheie D, Hall KS, van den Berg E, Mertens F, Picci P, Lothe RA, Heim S, Brandal P: IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors. Neuro-Oncology 16: 320-322, 2014,
• Håvik AB, Brandal P, Honne H, Dahlback HS, Scheie D, Hektoen M, Meling TR, Helseth E, Heim S, Lothe RA, Lind GE: MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR. Journal of translational medicine 10: 36, 2012,

Posters

• Håvik AB, Mejlænder-Andersen E, Wangensteen T, Vamre T, Fjeldvær MK, Rognlien VW, Ariansen SL: Detection of mosaicism for a pathogenic variant in BRCA1 in a diagnostic laboratory, 9362673
• Håvik AB, Cekaite L, Sveen A, Meling TR, Scheie D, Heim S, Lothe RA, Brandal P, Lind GE: Genome-wide expression profiling of malignant brain tumors - Distinguishing “look-alikes” from molecular relatives and identifying two novel candidate pathways in gliomas.,
• Håvik AB, Brandal P, Honne H, Dahlback HSS, Scheie D, Hektoen M,. Meling TR, Helseth E, Heim S, Lothe RA, Lind GE: Methylation of the MGMT promoter in Gliomas - Assessment by Quantitative MSP and Pyrosequencing.,

Contact information to references will be avaliebale on request.